Neurology® Podcast
SPECIAL REPORT on Aducanumab Approval: Steve Pearson of ICER Discusses the Economic and Clinical Impact
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:30:37
- Mas informaciones
Informações:
Sinopsis
Dr. Jason Crowell speaks with Dr. Steve Pearson, President of the Institute for Clinical and Economic Review, about the clinical and economic impact of aducanumab, a drug recently approved by the FDA for the treatment of Alzheimer disease.
